Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Oct 17, 2025

Total Value ($000): $744,419 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 65.0%

Value ($000) $484,107 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 11.8%

Value ($000) $87,858 Shares 7,464,572 Est. Cost $13.72 Unrealized -24.8%

NAMS NEWAMSTERDAM PHARMA COMPANY 11.0%

Value ($000) $81,610 Shares 2,869,565 Est. Cost $10.96 Unrealized +118.8%

— RAPT THERAPEUTICS INC 9.7%

Value ($000) $72,057 Shares 2,794,000 Est. Cost $25.79 Unrealized —

AURA AURA BIOSCIENCES INC 2.5%

Value ($000) $18,787 Shares 3,039,892 Est. Cost $17.87 Unrealized -63.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$484,107	65.0%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$87,858	11.8%	$13.72	-24.8%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$81,610	11.0%	$10.96	+118.8%	ORDINARY SHARES	N62509109
—	RAPT THERAPEUTICS INC	2,794,000	$72,057	9.7%	$25.79	—	COM	75382E109
AURA	AURA BIOSCIENCES INC	3,039,892	$18,787	2.5%	$17.87	-63.4%	COM	05153U107